---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-014840"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T14:16:46.632974+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma stockholders approve warrant-related share issuances from Dec 2024 private placement

## Summary
- Proposal 1 to issue >19.99% of shares upon Pre-Funded & Series A Warrants passed: 2,369,987 for, 24,205 against.
- Proposal 2 to issue shares to insiders upon warrant exercise approved: 2,370,124 for, 24,039 against.
- Quorum of 65.6% (2,396,188 shares) present; adjournment proposal not used as both prior proposals passed.

## SEC filing metadata
- accession: 0001104659-25-014840
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465925014840/0001104659-25-014840-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465925014840/tm256499d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-014840
- JSON: https://secwatch.observer/filing/0001104659-25-014840.json
- Plain text: https://secwatch.observer/filing/0001104659-25-014840.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.